Optimizing Patient Management and Adherence for Children Receiving Growth Hormone. [PDF]
, 2017 Poor adherence with growth hormone (GH) therapy has been associated with worse clinical outcomes, which in children relates specifically to their linear growth and loss of quality of life.
Carlo L. Acerini +3 more
core +3 more sources
Therapeutic Advances in Medical Oncology, 2014 Objectives: The recurrence of breast cancer during adjuvant hormone therapy is often targeted by second-line hormone therapy. However, there has been a lack of prior success with such treatments. We retrospectively investigated the efficacy of subsequent
Ryutaro Mori, Yasuko Nagao
doaj +1 more source
Growth hormone therapy in HHRH
Bone Reports, 2022 Background: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) (SLC34A3 gene, OMIM 241530) is an autosomal recessive disorder that results in a loss of function of the sodium-phosphate NPT2c channel at the proximal tubule.
Guido Filler, MD, PhD +6 more
doaj +1 more source
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate : A meta-analysis of 1446 patients [PDF]
, 2007 OBJECTIVE: To review pooled phase II data to identify features of different regimens of intermittent hormone therapy (IHT), developed to reduce the morbidity of treating metastatic prostate cancer, and which carries a theoretical advantage of delaying ...
Cuzick, Jack +6 more
core +1 more source
SAGE Open Medicine, 2014 Objective: According to the guidelines for metastatic breast cancer, hormone therapy for hormone receptor–positive metastatic breast cancer without life-threatening metastasis should be received prior to chemotherapy.
Ryutaro Mori, Yasuko Nagao
doaj +1 more source
Menopausal hormone therapy and venous thromboembolism
Menopause Review, 2014 Menopausal hormone therapy (MHT) is the most effective method of treating vasomotor symptoms and other climacteric symptoms related to estrogen deficiency in peri- and postmenopausal period.
Małgorzata Bińkowska
doaj +1 more source
The Clinical Significance of Subclinical Thyroid Dysfunction. [PDF]
, 2008 Subclinical thyroid disease (SCTD) is defined as serum free T(4) and free T(3) levels within their respective reference ranges in the presence of abnormal serum TSH levels.
BIONDI, BERNADETTE, COOPER DS
core +1 more source
Keratoconus progression associated with hormone replacement therapy
American Journal of Ophthalmology Case Reports, 2019 Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco +4 more
doaj +1 more source
Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study [PDF]
, 2005 Combined oral contraceptives,oral hormone replacement therapy and thrombophilias are recognised risk factors for venous thromboembolism in women.The objective of this study was to assess the risk of thromboembolism among women with thrombophilia who are ...
Brenkel, I. +10 more
core +1 more source
The Potential Effects of Hormonal Therapy and Stress on the Oral Health of the Transitioning Population [PDF]
, 2020 Problem: In terms of healthcare, the transgender population is underserved. Unfortunately, these individuals often experience stress related to seeking preventative care and fear discrimination.
Cantwell, Elena G, McClure, Devon
core +1 more source